Fatty acid imbalance might lead to novel treatments for CF.
Greener
M
M
D000818:Animals; D016718:Arachidonic Acid / Q000378:metabolism; D003550:Cystic Fibrosis / Q000175:diagnosis / Q000188:drug therapy* / Q000378:metabolism*; D019005:Cystic Fibrosis Transmembrane Conductance Regulator / Q000235:genetics / Q000378:metabolism; D004281:Docosahexaenoic Acids / Q000378:metabolism / Q000627:therapeutic use*; D005227:Fatty Acids / Q000378:metabolism*; D015525:Fatty Acids, Omega-3 / Q000378:metabolism / Q000627:therapeutic use; D005260:Female; D006801:Humans; D051379:Mice; D008822:Mice, Transgenic; D011247:Pregnancy
C505032:CFTR protein, human; D005227:Fatty Acids; D015525:Fatty Acids, Omega-3; D019005:Cystic Fibrosis Transmembrane Conductance Regulator; D004281:Docosahexaenoic Acids; D016718:Arachidonic Acid